Latest Balance Sheet News

Emerald Resources NL reports robust high-grade gold intercepts from its Dingo Range project in Western Australia and key Cambodian assets, reinforcing resource growth and underground development potential.

Pantera Minerals has seen a 37% uplift in the valuation of its EnergyX stake following an increase in EnergyX’s Regulation A raise price to US$13 per share, reflecting operational progress and stronger market confidence.

Challenger Limited reported a 19% jump in Life sales to $1.7 billion in Q3 FY26, driven by strong annuity demand and offshore growth. Despite a 10% dip in Funds Management FUM amid market volatility, the company advanced key retirement partnerships and tightened its FY26 EPS guidance.

Mitchell Services Limited (ASX: MSV) reported a 110% jump in quarterly EBITDA for Q3 FY26, driven by improved weather and stable operations, alongside a solid balance sheet with net debt under $1 million post-dividend.

KMD Brands has secured NZ$11 million from its retail entitlement offer, with a 52% participation rate. The company now moves to clear a 169 million share shortfall through a retail bookbuild, while shares remain halted ahead of trading resumption.

Yancoal’s March quarter report reveals stable coal output amid rising diesel prices pushing operating costs higher, alongside progress on its $2.6 billion Kestrel Coal Mine acquisition. The company’s safety performance improved and market coal prices gained momentum, with realized price benefits expected from Q2.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

Cosmo Metals is gearing up for a significant drilling campaign at its Kanowna Gold Project near Kalgoorlie, while systematic exploration at its NSW projects has revealed two high-priority copper-gold VMS targets. The company also bolstered its balance sheet with a $1.55 million entitlement offer to fund ongoing work.

Stanmore Resources defied a four-year low in metallurgical coal prices to deliver record saleable production and robust cash flow in 2025, while maintaining a strong safety record and advancing key development projects.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

Patrys has raised A$3.2 million through a share placement to fund its injectable quetiapine program’s Phase 1A clinical trial and FDA pre-IND preparations.

Janus Electric has unveiled a comprehensive growth strategy targeting over 1,600 electrified heavy trucks by FY29, leveraging its unique retrofit and battery swap technology across multiple international markets.